All In Biotech

Drug Trial Radar · NCT03253094

Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

Last checked: Nov 20, 2026Latest source record: Aug 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 186 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

186

Actual

Start

Aug 1, 2017

Primary completion

May 4, 2018

Study completion May 4, 2018

Sponsor

Lead sponsor
Scynexis, Inc.Industry
Sponsor type
Industry
First posted
Aug 17, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, double-dummy, active-controlled, dose-finding study to compare the efficacy, safety and tolerability of oral SCY-078 versus oral fluconazole in adult female subjects 18 years and older with moderate to severe Acute Vulvovaginal Candidiasis (AVVC). Approximately 180 eligible subjects (30 subjects per treatment group) will be enrolled and randomized into the study.

Conditions

  • Candida Vulvovaginitis

Interventions

  • FluconazoleDrug

    Oral Antifungal comparator

  • SCY-078Drug

    Investigational Antifungal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Cure (Complete Resolution of Signs and Symptoms)Time frame: 8-12 days

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • UAB Personal Health Clinic

    Birmingham, Alabama

  • Precision Trials AZ, LLC

    Phoenix, Arizona

  • Women's Health Care Research Corp.

    San Diego, California

  • Gulf Coast Research Group, LLC

    Brandon, Florida

  • Altus Research, Inc.

    Lake Worth, Florida

  • OB-GYN Associates of Mid-Florida P.A.

    Leesburg, Florida

  • New Age Medical Research Corp.

    Miami, Florida

  • Visionary Investigators Network

    South Miami, Florida

  • Atlanta North Gynecology, P.C.

    Roswell, Georgia

  • Cypress Medical Research Center, LLC

    Wichita, Kansas

  • Clinical Trials Management, LLC

    Covington, Louisiana

  • Clinical Trials Management, LLC

    Metairie, Louisiana

  • Women Under Study, LLC

    New Orleans, Louisiana

  • Tolan Park Medical Building

    Detroit, Michigan

  • Consultants in Women's Healthcare, Inc.

    St Louis, Missouri

  • Lawrence OB/GYN Clinical Research, LLC

    Lawrenceville, New Jersey

  • Women's Health Research Center

    Plainsboro, New Jersey

  • Unified Women's Clinical Research - Central Carolina

    Greensboro, North Carolina

  • Wake Research Associates, LLC

    Raleigh, North Carolina

  • Drexel University

    Philadelphia, Pennsylvania

  • Medical Research South, LLC

    Charleston, South Carolina

  • WR-Medical Research Center of Memphis, LLC

    Memphis, Tennessee

  • Tmc Life Research, Inc.

    Houston, Texas

  • Clinical Trials of Texas, Inc.

    San Antonio, Texas

  • Seattle Women's Health, Research, Gynecology

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.